Growth Poles and Growth Centres in Regional Planning.by A. R. Kuklinski
- 期刊名称The Economic Journal
- 作者Review by: B. Moore
- 卷第84卷
- 期第336期
- 印刷ISSN0013-0133
- 电子ISSN1468-0297
- 文件大小392.63KB
- 发表时间1974-12
- DOI10.2307/2230600
- 页码1019-1021
Weight Loss during Telaprevir-based Triple Therapy due to Telaprevir-induced Appetite LossNomura, Hideyuki; Miyagi, Yuugou; Tanimoto, Hironori; Kawano, Akira; Yamashita, Nobuyuki · Internal Medicine · 2014
Telaprevir Twice Daily Is Noninferior to Telaprevir Every 8 Hours for Patients With Chronic Hepatitis CButi, Maria; Agarwal, Kosh; Horsmans, Yves; Sievert, William; Janczewska, Ewa; Zeuzem, Stefan; Nyberg, Lisa; Brown, Robert S.; Hézode, Christophe; Rizzetto, Mario; Paraná, Raymundo; De Meyer, Sandra; De Masi, Ralph; Luo, Donghan; Bertelsen, Kirk; Witek, James · Gastroenterology · 2014
Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis CKarino, Y.; Ozeki, I.; Hige, S.; Kimura, M.; Arakawa, T.; Nakajima, T.; Kuwata, Y.; Sato, T.; Ohmura, T.; Toyota, J. · Journal of Viral Hepatitis · 2014
Anti-interferon-α neutralizing antibody induced telaprevir resistance under the interferon-α plus telaprevir treatment in vitroKuga, Chisa; Enomoto, Hirayuki; Aizawa, Nobuhiro; Takashima, Tomoyuki; Ikeda, Naoto; Ishii, Akio; Sakai, Yoshiyuki; Iwata, Yoshinori; Tanaka, Hironori; Saito, Masaki; Iijma, Hiroko; Nishiguchi, Shuhei · Biochemical and Biophysical Research Communications · 2014
Sustained virological response with telaprevir in 1078 patients with advanced hepatitis C: The international telaprevir access programColombo, Massimo; Strasser, Simone; Moreno, Christophe; Abrao Ferreira, Paulo; Urbanek, Petr; Fernández, Inmaculada; Abdurakmonov, Djamal; Streinu-Cercel, Adrian; Verheyen, Anke; Iraqi, Wafae; DeMasi, Ralph; Hill, Andrew; Lonjon-Domanec, Isabelle; Wedemeyer, Heiner · Journal of Hepatology · 2014
Therapeutic drug monitoring of telaprevir in chronic hepatitis C patients receiving telaprevir-based triple therapy is useful for predicting virological responseFurusyo, N.; Ogawa, E.; Murata, M.; Toyoda, K.; Ohnishi, H.; Eiraku, K.; Shimizu, M.; Harada, Y.; Mitsumoto, F.; Takayama, K.; Kainuma, M.; Okada, K.; Hayashi, J. · Journal of Antimicrobial Chemotherapy · 2014
898 TREATMENT WITH TELAPREVIR/PEG-IFN/RBV AFTER 14-DAY TELAPREVIR EXPOSURE IN PHASE I STUDIES: RESULTS FROM THE PHASE IIIB C219 ROLLOVER STUDYSarrazin, C.; Reesink, H.W.; Zeuzem, S.; Dierynck, I.; Luo, D.; Witek, J.; Picchio, G.; De Meyer, S. · Journal of Hepatology · 2013
P1199 RE-TREATMENT WITH TELAPREVIR-BASED TRIPLE THERAPY AFTER TELAPREVIR EXPOSURE IN PHASE 1 STUDIES: DEEP SEQUENCE ANALYSIS FOR PERSISTENCE OF RESISTANT VARIANTSSusser, S.; Flinders, M.; Reesink, H.W.; Zeuzem, S.; Lawyer, G.; Ghys, A.; Van Eygen, V.; Witek, J.; De Meyer, S.; Sarrazin, C. · Journal of Hepatology · 2014
Biperiden/trihexyphenidylReactions Weekly · 1995
NitrendipineReactions Weekly · 2003
ScopolamineReactions Weekly · 2007
ScopolamineReactions Weekly · 2012
ScopolamineReactions Weekly · 2009
Centella asiaticaReactions Weekly · 2011
Daunorubicin/mitoxantroneReactions Weekly · 2007
AnthracyclinesReactions Weekly · 1991